| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $17K | -85.7% |
| Cost of Revenue | $13K | -87.2% |
| Gross Profit | $4K | -77.7% |
| R&D Expense | $187K | +0.0% |
| SG&A Expense | $383K | +42.3% |
| Operating Income | -$2.8M | -248.8% |
| Pre-tax Income | -$3.0M | -180.2% |
| Net Income | -$3.0M | -180.2% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $215K | -53.7% |
| Accounts Receivable | $3K | +0.0% |
| Inventory | $46K | +411.6% |
| Current Assets | $265K | -46.1% |
| Total Assets | $340K | -42.6% |
| Current Liabilities | $300K | +17.5% |
| Total Liabilities | $308K | +20.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$503K | +26.4% |
| Capital Expenditures | $125K | +0.0% |
| Investing Cash Flow | -$125K | +0.0% |
| Financing Cash Flow | $254K | -54.0% |
| Free Cash Flow | -$628K | +22.3% |
| $32K |
| -90.5% |